Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q3

2372.TEDINET S100Q33O
Period2022-04-01 → 2022-12-31
Filed2023-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥13.9bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥15.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥11.7bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥3.0bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥2.2bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥2.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥2.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥3.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.8bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥1.8bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥32.2bnat 2022-12-31Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥26.1bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥20.4bnat 2022-12-31Cons.Liabilities
Total liabilities¥16.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥11.8bnat 2022-12-31Cons.Net assets
Net assets / equity¥10.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥9.9bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥8.3bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥6.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥185.132022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.052022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥147.382021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥87.362021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥184.942022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.172021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥147.062021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio36.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.7%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥104m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥58m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥46m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥237m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥953m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥953m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥996m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31−¥100m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-12-31¥4.1bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.0bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥97m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-12-31−¥70m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-12-31¥776m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥691m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-12-31¥69m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-12-31¥8.1bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-12-31¥8.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥115m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-12-31¥4.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥14.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥13.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥907m
—segment totalsegment profit2022-04-01 → 2022-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥14.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥953m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥4.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥55m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥12m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥142m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥811m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥811m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2021-04-01 → 2021-12-31¥489m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2021-04-01 → 2021-12-31¥486m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥3m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2021-04-01 → 2021-12-31−¥452m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2021-04-01 → 2021-12-31¥3.8bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2021-04-01 → 2021-12-31¥3.7bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥50m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2021-04-01 → 2021-12-31¥435m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2021-04-01 → 2021-12-31¥1.4bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2021-04-01 → 2021-12-31¥774m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥589m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2021-04-01 → 2021-12-31¥233m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2021-04-01 → 2021-12-31¥6.8bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2021-04-01 → 2021-12-31¥6.7bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥124m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2021-04-01 → 2021-12-31¥3.1bn
—segment totalrevenue2021-04-01 → 2021-12-31¥12.4bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥11.7bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥767m
—segment totalsegment profit2021-04-01 → 2021-12-31¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥12.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥11.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥811m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥3.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 416
ItemContextValueUnit
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember13896000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration13896000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E05352-000SMOReportableSegmentsMember115000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E05352-000CROReportableSegmentMember97000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E05352-000AdvancedMedicalReportableSegmentsMember2000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E05352-000MedicalSupportReportableSegmentsMember691000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember907000000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember46000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember953000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-953000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000SMOReportableSegmentsMember8149000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000CROReportableSegmentMember4063000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000AdvancedMedicalReportableSegmentsMember1066000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000MedicalSupportReportableSegmentsMember1467000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember14746000000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember104000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember14850000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-953000000JPY
Net salesCurrentYTDDuration13896000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000SMOReportableSegmentsMember4363000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000CROReportableSegmentMember-70000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000AdvancedMedicalReportableSegmentsMember-100000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000MedicalSupportReportableSegmentsMember69000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember4262000000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-237000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember4024000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-996000000JPY
Operating incomeCurrentYTDDuration3027000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-02-08
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第26期第３四半期（自　2022年10月１日　至　2022年12月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社アイロムグループ
Company name in english cover pageFilingDateInstantI'rom Group Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　森　豊隆
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区富士見二丁目10番２号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03（3264）3148（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)専務取締役　経営管理センター担当　　犬飼　広明
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区富士見二丁目10番２号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03（3264）3148（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)専務取締役　経営管理センター担当　　犬飼　広明
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE05352
Fund codeFilingDateInstant－
Security codeFilingDateInstant23720
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社アイロムグループ
Filer name in englishFilingDateInstantI'rom Group Co., Ltd.

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass